These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 8398573

  • 1. The comparative effects of IL-1 and TNF on AMN-anti-Ly 2.1 immunoconjugate therapy.
    Krauer KG, Pietersz GA.
    Biotherapy; 1993; 6(2):139-47. PubMed ID: 8398573
    [Abstract] [Full Text] [Related]

  • 2. Tumour eradication with high-dose idarubicin-anti-Ly-2.1 with murine tumour necrosis factor-alpha in mice.
    Pietersz GA, Bogdanovski M, Li W.
    Immunol Cell Biol; 1997 Jun; 75(3):253-8. PubMed ID: 9243290
    [Abstract] [Full Text] [Related]

  • 3. Effect of tumor necrosis factor on the antitumor efficacy and toxicity of aminopterin-monoclonal antibody conjugates: parameters for optimization of therapy.
    Russell SM, Krauer KG, McKenzie IF, Pietersz GA.
    Cancer Res; 1990 Sep 15; 50(18):6028-33. PubMed ID: 2393867
    [Abstract] [Full Text] [Related]

  • 4. Reduction in the toxicity of aminopterin--monoclonal-antibody conjugates by leucovorin.
    Rowland AJ, Pietersz GA.
    Cancer Immunol Immunother; 1994 Aug 15; 39(2):135-9. PubMed ID: 8044832
    [Abstract] [Full Text] [Related]

  • 5. Anti-tumour activity of aminopterin-monoclonal antibody conjugates; in vitro and in vivo comparison with methotrexate-monoclonal antibody conjugates.
    Kanellos J, Pietersz GA, Cunningham Z, McKenzie IF.
    Immunol Cell Biol; 1987 Dec 15; 65 ( Pt 6)():483-93. PubMed ID: 3502340
    [Abstract] [Full Text] [Related]

  • 6. The role of TNF-alpha in fever: opposing actions of human and murine TNF-alpha and interactions with IL-beta in the rat.
    Stefferl A, Hopkins SJ, Rothwell NJ, Luheshi GN.
    Br J Pharmacol; 1996 Aug 15; 118(8):1919-24. PubMed ID: 8864524
    [Abstract] [Full Text] [Related]

  • 7. Enhanced antitumour effects using a combination of two antibodies conjugated to different drugs.
    Rowland AJ, McKenzie IF, Pietersz GA.
    J Drug Target; 1994 Aug 15; 2(2):113-21. PubMed ID: 8069589
    [Abstract] [Full Text] [Related]

  • 8. Antitumor effect of 2'-deoxy-5-fluorouridine conjugates against a murine thymoma and colon carcinoma xenografts.
    Krauer KG, McKenzie IF, Pietersz GA.
    Cancer Res; 1992 Jan 01; 52(1):132-7. PubMed ID: 1530766
    [Abstract] [Full Text] [Related]

  • 9. Role of tumor necrosis factor species in the sequence-dependent effects of interleukin-2--tumor necrosis factor immunotherapy in mice: implications for preclinical cytokine testing.
    Owen-Schaub LB, Santee SM, Winkelhake JL, Zimmerman RJ.
    J Immunother Emphasis Tumor Immunol; 1994 Jan 01; 15(1):1-10. PubMed ID: 8110725
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vitro and in vivo evaluation of human tumor necrosis factor-alpha (hTNFalpha) chemically conjugated to monoclonal antibody.
    Pietersz GA, Toohey B, McKenzie IF.
    J Drug Target; 1998 Jan 01; 5(2):109-20. PubMed ID: 9588867
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Induction of interleukin 6 by human and murine recombinant interleukin 1 in mice.
    Libert C, Brouckaert P, Shaw A, Fiers W.
    Eur J Immunol; 1990 Mar 01; 20(3):691-4. PubMed ID: 2318254
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Increased antitumor effect of immunoconjugates and tumor necrosis factor in vivo.
    Smyth MJ, Pietersz GA, McKenzie IF.
    Cancer Res; 1988 Jul 01; 48(13):3607-12. PubMed ID: 3259905
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Limited involvement of interleukin-6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin-6 or its receptor in various murine models.
    Libert C, Vink A, Coulie P, Brouckaert P, Everaerdt B, Van Snick J, Fiers W.
    Eur J Immunol; 1992 Oct 01; 22(10):2625-30. PubMed ID: 1327800
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.